DKLL
Ranbaxy

SUN PHARMACEUTICAL CO.

Featured products of Sun Pharmaceutical
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
sunitinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
sunitinib
Packing/Price
4 × 7's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Distributed by DKLL
sunitinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
sunitinib
Packing/Price
4 × 7's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Marketed by Ranbaxy
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
rivaroxaban
Packing/Price
3 × 10's
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AF01 - rivaroxaban : Belongs to the class of direct factor Xa inhibitors. Used in the treatment of thrombosis.
sunitinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
sunitinib
Packing/Price
4 × 7's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX01 - sunitinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
pemetrexed
Packing/Price
1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.